procedure, the effect of the treatment was confirmed by showing a lack of enhancement by CEUS, indicating destruction of the node. Patients were followed by ultrasonography, serum thyroglobulin (Tg), and PET/ CT at 6 and 12 months after the procedure.
One patient had extensive progression of lung and lymph-node recurrence and was excluded from further follow-up. At the 12-month follow-up, 16 of 20 treated nodes were negative on imaging. Local control was achieved in 10 of the 14 patients, but lung metastasis developed in 1. In 3 other patients with apparent local control, Tg was elevated.
Conclusions
Percutaneous laser ablation is a feasible, safe, and effective treatment for cervical nodal recurrence of PTC.
SUMMARY

Background
Papillary thyroid carcinoma (PTC) frequently metastasizes to cervical lymph nodes. The recurrence can be identified by ultrasonography and FNA of the abnormal nodes. At present, the therapy for this recurrence is either 131 I or surgical resection. This study describes percutaneous laser ablation (PLA) of metastatic cervical nodes, a new therapy.
Methods
Fifteen patients were included in the study, and all had at least 6 months of follow-up after PLA. The procedure was applied to 24 newly identified lymphnode recurrences in patients who had undergone thyroidectomy and radioiodine ablation. At the time of recurrence, the patients had uptake of FDG in the node on PET/CT but had a negative radioiodine scan.
Each lymph node was identified by ultrasound and by contrast-enhanced ultrasound (CEUS). The ablation procedure was performed using a commercially available ultrasound system with an integrated laser source under local anesthesia. Introducer needles were placed in the lymph node, an optic fiber was advanced to the needle tip, and laser power was administered to cover several millimeters more than the volume of the nodule. At the end of the 
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This small series shows the potential efficacy of this new procedure. It is technically demanding and requires that the interventionist possess skills in ultrasonography and laser therapy. The results of this study were similar to another recent series that included only five patients (1).
In patients with aggressive PTC, the usual first-line therapy for cervical recurrence is extensive neck dissection, but this is successful in only about threefourths of patients. For patients with radioiodine uptake in nodes, 131 I may eradicate the recurrence, but it is certainly not uniformly successful; apparently, none of the patients in this series had radioiodine uptake in their nodes. Fortunately, the armamentarium for treatment of cervical recurrences is rapidly increasing and now includes alcohol injection, radiofrequency, microwaves, and cryoablation in addition to PLA (2, 3) . Each technique requires special expertise. As experience accrues with PLA and these other methods, it will be worthwhile to compare the results of these methods to each other and to those achieved with surgical therapy.
I hope to hear from our readership with regard to your use of these new techniques for treatment of recurrent cervical nodes.
